171 related articles for article (PubMed ID: 26708806)
1. The role of ATP-binding cassette transporter genes in the progression of prostate cancer.
Karatas OF; Guzel E; Duz MB; Ittmann M; Ozen M
Prostate; 2016 Apr; 76(5):434-44. PubMed ID: 26708806
[TBL] [Abstract][Full Text] [Related]
2. Frequent down-regulation of ABC transporter genes in prostate cancer.
Demidenko R; Razanauskas D; Daniunaite K; Lazutka JR; Jankevicius F; Jarmalaite S
BMC Cancer; 2015 Oct; 15():683. PubMed ID: 26459268
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138
[TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs.
Borel F; Han R; Visser A; Petry H; van Deventer SJ; Jansen PL; Konstantinova P;
Hepatology; 2012 Mar; 55(3):821-32. PubMed ID: 21932399
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as prognostic markers in prostate cancer.
Suer I; Guzel E; Karatas OF; Creighton CJ; Ittmann M; Ozen M
Prostate; 2019 Feb; 79(3):265-271. PubMed ID: 30345533
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2021 Feb; 48(2):1393-1400. PubMed ID: 33506275
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.
Park S; Shimizu C; Shimoyama T; Takeda M; Ando M; Kohno T; Katsumata N; Kang YK; Nishio K; Fujiwara Y
Breast Cancer Res Treat; 2006 Sep; 99(1):9-17. PubMed ID: 16752223
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ATP-binding cassette transporter genes in nasopharyngeal carcinoma].
DU SS; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):449-52. PubMed ID: 18359711
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort.
Rubicz R; Zhao S; April C; Wright JL; Kolb S; Coleman I; Lin DW; Nelson PS; Ostrander EA; Feng Z; Fan JB; Stanford JL
Prostate; 2015 Sep; 75(13):1354-62. PubMed ID: 25990700
[TBL] [Abstract][Full Text] [Related]
12. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
Heimerl S; Bosserhoff AK; Langmann T; Ecker J; Schmitz G
Melanoma Res; 2007 Oct; 17(5):265-73. PubMed ID: 17885581
[TBL] [Abstract][Full Text] [Related]
13. ABC transporter gene expression in benign and malignant ovarian tissue.
Auner V; Sehouli J; Oskay-Oezcelik G; Horvat R; Speiser P; Zeillinger R
Gynecol Oncol; 2010 May; 117(2):198-201. PubMed ID: 19922990
[TBL] [Abstract][Full Text] [Related]
14. Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates.
Roy LO; Lemelin M; Blanchette M; Poirier MB; Aldakhil S; Fortin D
J Neurooncol; 2022 Dec; 160(3):601-609. PubMed ID: 36342588
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance and molecular mechanisms of adenosine triphosphate-binding cassette subfamily C members in gastric cancer.
Mao X; He Z; Zhou F; Huang Y; Zhu G
Medicine (Baltimore); 2019 Dec; 98(50):e18347. PubMed ID: 31852133
[TBL] [Abstract][Full Text] [Related]
16. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
[TBL] [Abstract][Full Text] [Related]
17. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
Varatharajan S; Abraham A; Karathedath S; Ganesan S; Lakshmi KM; Arthur N; Srivastava VM; George B; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2017 Feb; 18(3):235-244. PubMed ID: 28112576
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
19. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.
Warren MS; Zerangue N; Woodford K; Roberts LM; Tate EH; Feng B; Li C; Feuerstein TJ; Gibbs J; Smith B; de Morais SM; Dower WJ; Koller KJ
Pharmacol Res; 2009 Jun; 59(6):404-13. PubMed ID: 19429473
[TBL] [Abstract][Full Text] [Related]
20. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
